Use of Novel Biomarkers for Detection of Testicular Carcinoma in Situ and Derived Cancers in Human Samples

The present invention relates to methods and kits for identification of testicular carcinoma in situ (CIS), gonadoblastoma (a CIS-like pre-cancerous lesion found in dysgenetic gonads) and CIS-derived cancers based on at least one of the biomarkers included in the invention. It also relates to diagnosis of a subject's status of the testicular carcinoma in situ and the derived cancers based on the measurement of a relative abundance of one of the biomarkers.

Attached files:


Patents:
AT 503,186

Inventor(s): ALMSTRUP KRISTIAN [DK]; HYI-HANSEN CHRISTINA [DK]; RAJPERT-DE MEYTS EWA [DK]; WIRKNER UTE [DE]; ANSORGE WILHELM [CH]; LEFFERS HE

Type of Offer: Sale



« More Biotech Patents

---